Group 1 - The stock of Jingyou Pharmaceutical (00858) surged over 13%, reaching a price of 0.134 HKD with a trading volume of 2.323 million HKD [1] - The company entered into subscription agreements with three different parties on August 14, 2025, for a total of 300 million HKD in new shares at a price of 0.097 HKD per share [1][2] - The total amount from the subscription agreements is 2.91 million HKD, 1.94 million HKD, and 10.67 million HKD respectively, with conditions that must be met for the agreements to be finalized [1][2] Group 2 - The net proceeds from the subscription agreements will be used for the development of new business opportunities in health products, equipment, and technology trade in China, as well as expanding into overseas markets [2] - The company will continue to utilize its existing cash resources to maintain and develop its current pharmaceutical business [2]
港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股 净筹款项用于潜在新业务发展